{
    "title": "Pfizer COVID vaccine price hike to boost revenue for years, rivals may follow",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11341653/Pfizer-COVID-vaccine-price-hike-boost-revenue-years-rivals-follow.html",
    "date": "2022-10-21",
    "keywords": [
        "price",
        "vaccine",
        "range",
        "revenue",
        "shot",
        "pricing",
        "pfizer",
        "year",
        "market",
        "moderna",
        "erman",
        "covid19",
        "demand",
        "thursday",
        "analyst",
        "share",
        "research",
        "note",
        "covid",
        "announcement",
        "trizzino",
        "booster",
        "drugmaker",
        "germanys",
        "biontech",
        "evening",
        "dose",
        "move",
        "afternoon",
        "trading",
        "pfizerbiontech",
        "distribution",
        "model",
        "mohit",
        "bansal",
        "assumption",
        "access",
        "group",
        "alliance",
        "hike",
        "markup",
        "cost",
        "program",
        "government",
        "flu",
        "light",
        "novavax",
        "svb",
        "david",
        "risinger",
        "future",
        "foothold",
        "officer",
        "john",
        "company",
        "healthcare",
        "extent",
        "something",
        "order",
        "lever",
        "street",
        "rollout",
        "eligibility",
        "revaccination",
        "campaign",
        "point",
        "reporting",
        "humer",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}